•   Home
• About Us
• Equity
• Derivatives
• Currency
• IPO
• Mutual Funds
• NRI Corner
• Depository
• Membership
•   Contact Us 

• Market Tracker
• Company Information
•   Corporate Actions
• News Analysis
• Other Markets

Profit and Loss

Cohance Lifesciences Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R) 543064 INE03QK01018 60.8611266 COHANCE 0 38029.09 140.01 7.1 1

Mar 2024 (Rs.Cr) Mar 2023 (Rs.Cr) Mar 2022 (Rs.Cr) Mar 2021 (Rs.Cr) Mar 2020 (Rs.Cr) Mar 2019 (Rs.Cr) INCOME :             Sales Turnover 1024.99 1330.08 1320.22 1009.72 833.79 377.83 Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00 Net Sales 1024.99 1330.08 1320.22 1009.72 833.79 377.83 Other Income 55.09 44.55 187.79 14.24 18.12 0.60 Stock Adjustments -53.88 20.94 60.35 8.37 11.05 21.32 Total Income 1026.20 1395.57 1568.36 1032.33 862.96 399.75 EXPENDITURE :             Raw Materials 248.38 421.36 459.46 310.32 240.24 124.52 Power & Fuel Cost 46.16 71.35 59.55 44.20 38.24 18.06 Employee Cost 126.88 108.58 100.48 76.23 65.10 29.63 Other Manufacturing Expenses 83.19 101.96 115.25 90.76 66.49 33.83 Selling & Administrative Expenses 38.85 43.57 52.38 44.93 44.72 16.23 Miscellaneous Expenses 17.75 13.50 11.17 8.61 5.26 5.34 Less : Pre-operative Expenses Capitalised 0.00 0.00 0.00 0.00 0.00 0.00 Total Expenditure 561.21 760.33 798.29 575.05 460.05 227.60 Operating Profit 465.00 635.24 770.08 457.28 402.91 172.15 Interest 7.43 12.75 8.53 11.66 21.81 2.79 Gross Profit 457.57 622.49 761.55 445.62 381.10 169.36 Depreciation 48.79 43.10 39.10 31.64 23.51 11.50 Profit Before Tax 408.78 579.39 722.45 413.98 357.59 157.86 Tax 97.37 142.45 157.63 101.72 88.81 33.17 Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00 Deferred Tax 6.59 4.34 6.72 3.62 -1.30 15.42 Reported Net Profit 304.82 432.60 558.10 308.65 270.08 109.27 Extraordinary Items 32.53 10.55 14.53 2.51 4.73 0.11 Adjusted Net Profit 272.29 422.05 543.57 306.14 265.35 109.16 Adjustment below Net Profit -0.30 -0.26 -0.76 -0.84 -13.90 315.80 P & L Balance brought forward 1490.07 1276.39 835.88 568.52 390.98 0.00 Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00 Appropriations 0.00 218.65 116.83 40.46 78.64 34.09 P & L Balance carried down 1794.59 1490.07 1276.39 835.88 568.52 390.98 Dividend 0.00 0.00 0.00 0.00 0.00 0.00 Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00 Equity Dividend % 0.00 600.00 500.00 200.00 500.00 0.00 Dividend Per Share(Rs) 0.00 6.00 5.00 2.00 5.00 0.00 Earnings Per Share-Unit Curr 11.97 16.99 21.92 12.12 21.22 20.60 Earnings Per Share(Adj)-Unit Curr 11.97 16.99 21.92 12.12 10.61 20.60 Book Value-Unit Curr 80.76 68.72 59.74 41.84 61.50 0.00 Book Value(Adj)-Unit Curr 80.76 68.72 59.74 41.84 30.75 0.00